A randomized, double-blind, placebo-controlled clinical trial of fluoride varnish in preventing dental caries of Sjögren’s syndrome patients by Mok, M.Y. et al.
Title
A randomized, double-blind, placebo-controlled clinical trial of
fluoride varnish in preventing dental caries of Sjögren’s
syndrome patients
Author(s) Xin, W.N.; Leung, KCM; Lo, ECM; Mok, M.Y.; Leung, M.H.
Citation BMC Oral Health, 2016, v. 16, p. 102:1-11
Issued Date 2016
URL http://hdl.handle.net/10722/240226
Rights
BMC Oral Health. Copyright © BioMed Central Ltd.; This work is
licensed under a Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License.
RESEARCH ARTICLE Open Access
A randomized, double-blind, placebo-
controlled clinical trial of fluoride varnish in
preventing dental caries of Sjögren’s
syndrome patients
Weini Xin1, Katherine Chiu Man Leung2*, Edward Chin Man Lo3, Mo Yin Mok4 and Moon Ho Leung5
Abstract
Background: Sjögren’s syndrome (SS) patients are prone to caries development due to reduction of salivary flow.
Topical fluoride is commonly prescribed for caries prevention.
Methods: In this 24-month randomized, double-blind, placebo-controlled clinical trial, SS patients were randomly
assigned to receive either fluoride varnish or placebo gel quarterly. Development and arrest of caries at the coronal
and root surfaces were recorded at 12-month and 24-month and compared to that of the baseline. Effect of
fluoride varnish on oral Candida and lactobacilli colonization was explored by comparing baseline oral microbiological
assessments to data obtained at 12-month and 24-month.
Results: Seventy-eight SS patients (mean age = 50 years, 2 men) completed this trial. At 24-month, the mean new
coronal enamel caries were 1.6 surfaces in both groups, and new dentin caries were 1.4 and 2.7 surfaces in the fluoride
and placebo group respectively (p > 0.05). Mean arrested caries were 0.6 and 0.7 surfaces for fluoride and placebo
groups respectively and that of root caries were 0.3 and 0.1 surfaces (p > 0.05). The mean oral Candida count was
reduced by 30% in the fluoride group but increased 61% in the placebo group while no change in oral lactobacilli
counts in both groups at 24 months (p > 0.05). SS patients receiving fluoride varnish were significantly less likely to
develop dentin caries (p < 0.05). In contrast, those with high baseline DMFS scores (p = 0.05), harbored mixed Candida
species (p < 0.05), or unstimulated whole saliva at low pH (p < 0.01) were significantly more likely to develop dentin
caries.
Conclusions: Results of this randomized clinical trial did not provide clear evidence to support or refute that quarterly
applications of fluoride varnish can prevent development of dental caries in people with Sjögren’s syndrome.
Trial registration: This study was retrospectively registered at the ISRCTN registry (ISRCTN85164658) on 9 Sept 2016
and was funded by the Research Grant Council of Hong Kong.
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Background
Sjögren’s syndrome (SS) is a slowly progressive auto-
immune disorder of exocrine glands which is character-
ized by intense lymphocytic infiltration [1]. Salivary and
lacrimal glands are the most commonly affected exo-
crine glands, resulting in reduced secretion of saliva
(hyposalivation) and tears [2].
SS patients often complain of dry mouth (xerostomia).
Reduction in salivary flow rate and high caries occur-
rence have also been reported in previous studies [3]. In
addition, there is a high prevalence of SS sufferers pre-
sented with oral colonization of pathological micro-
organisms such as lactobacilli and Candida [4].
Prevention of dental caries in SS patients is important.
Topical fluoride has been extensively used to prevent
caries in children and elderly people, however, little evi-
dence is available for its efficacy in SS patients at present.
Most fluoride varnishes contain 22600 ppm fluoride. It
has been reported to effectively prevent enamel caries and
dentin caries, and to arrest initial caries lesions in children
and adolescent [5, 6]. The Sjögren’s Syndrome Foundation
Clinical Practice Guidelines Committee strongly recom-
mends the use of topical fluoride [7]. The American
Dental Association (ADA) suggests that people at moder-
ate risk should receive fluoride varnish or gel applications
at 6-month intervals and higher-risk patients at three- to
6-month intervals [8].
The current study reports a randomized, double-blind,
placebo-controlled clinical trial with the primary aim of
investigating the efficacy of fluoride varnish in prevent-
ing dental caries in Chinese patients with SS. The effect
of fluoride varnish on oral colonization of Candida and
lactobacilli in Chinese patients with SS over a 24-month
period will also be investigated.
Methods
Study design and participants
This was a parallel study. Randomized, double-blind,
placebo-controlled clinical trial design which lasted for
24 months was employed. Dental records of 15 SS pa-
tients were randomly selected from those who had par-
ticipated in previous consecutive studies revealed a
mean caries increment of 3.5 surfaces (SD = 2.8) over
24 months [3]. Assuming the caries preventive fraction
of fluoride varnish was 35% [9], the estimated 24-month
mean caries increment of the fluoride group would be
2.3 surfaces (SD = 1.8). The estimated minimum sample
size was 48 per group to achieve α = 0.05 and β = 80%.
Allowing for a 10% annual dropout, 120 SS patients was
planned.
SS patients were recruited from the Rheumatology
Clinics of the Queen Mary Hospital (QMH) and Queen
Elizabeth Hospital (QEH), Hong Kong. These two hospi-
tals were selected because they were the two largest
public hospitals in Hong Kong and are within 30 minutes
travelling time to the Prince Philip Dental Hospital
(PPDH). Patients from QMH and QEH are comparable
in terms of ethnic origin, diet and culture. Diagnosis
of SS was established using the American-European
Consensus Group (AECG) criteria [10] at least 6 months
before the commencement of this study. Potential recruits
were excluded if they were under 18 years of age, had less
than 8 natural teeth, had severe periodontal disease (e.g.,
periodontal pockets were deeper than 6 mm at two or
more sextants), had received therapeutic irradiation to the
head and neck region, had concurrent systemic illness
(except connective tissue disorder associated with sSS),
were taking medication that altered salivary flow, or had
participated in a clinical trial within 6 months before com-
mencement of this trial. Socio-demographic information
regarding education level, employment status, and oral hy-
giene measures were obtained. To ensure comparability of
the characteristics of the subjects in the intervention and
control groups, a stratified block randomization method
with a block size of four was applied so that a similar
number of pSS and sSS subjects were allocated to each
group [11]. Concealment of participant allocation was
kept by a clinical staff who was not involved in the trial.
Topical applications of fluoride varnish or placebo gel
were carried out by one hospital dentist who was not in-
volved in research team. Blinding of the participants and
the examiner was maintained until all clinical data were
collected at 24-month.
All recruited subjects were invited to attend a pre-
baseline full-mouth oral and dental examination at the
PPDH. Bitewing radiographs were taken to aid diagnosis
of caries. Standard oral hygiene instruction on tooth-
brushing and flossing was given and participants were
advised to brush twice a day and floss every day. Dental
treatments including scaling, tooth extraction, root canal
treatment, periodontal therapy and dental prosthesis
were provided if indicated. Restorations were provided
except for initial caries lesion and arrested non-cavitated
caries lesions. The use of fluoride-releasing restorative
materials was avoided. All treatments were completed at
least 14 days before commencement of the baseline data
collection.
Clinical procedure
All clinical procedures were carried out between
9:00 am and 12:00 noon in a surgery room at the PPDH.
Participants were advised to refrain from food or bever-
age intake (except water) one hour before the attending
dental examination. They were asked to rinse their
mouth with 10 ml of sterile phosphate-buffered saline
(PBS; 0.01 M; pH = 7.2) for 30s prior to collection in a
sterile container. Dentures, if present, were retained dur-
ing rinsing. The oral rinse sample was then sent for
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microbiological analysis. After resting for 5 min and
voiding the mouth, a sterile, pre-weighed plastic vial was
provided for collection of unstimulated whole saliva
(UWS). Over a period of 5 min, all saliva was drained
into the vial by drooling or gentle spitting. For stimu-
lated whole saliva (SWS) collection, subjects were
instructed to chew on a piece of sterilized silicone rub-
ber tubing (2 mm × 8 mm∅) and to spit all the saliva
into another sterile, pre-weighed plastic vial for 5 min.
The weights of vials were recorded and UWS and SWS
flow rates were determined and expressed as g/min. Im-
mediately after saliva collection, pH values and buffer
capacity of UWS and SWS were determined at chair side
using a pH meter (Sentron 501 Pocket FET pH meter,
Sentron, WA, USA) and a commercial strip (CRT® buf-
fer, Vivadent, Liechtenstein) respectively. Supra-gingival
dental plaque was collected from all accessible coronal
tooth surfaces of the whole mouth using a sterile sickle
scaler and then dispersed into a pre-weighed vial con-
taining 500 μl PBS.
The examiner was trained and calibrated before the
start of the baseline examination and recalibrated at 6-
month, 12-month, 18-month and 24-month. The exam-
iner received training through the “ICDAS E-Learning
Course” in the ICDAS official website. After calibration,
data collection was performed by the calibrated exam-
iner. To assess intra-examiner reliability, duplicate ex-
aminations were carried out on one in ten subjects.
The Silness-Löe plaque index [12] was modified where
score 0 denoted no plaque accumulation, and score 1
dental plaque accumulation when a WHO probe (Guilin
Woodpecker Medical Instrument Co., Ltd) was run
along the gingival margins of the index teeth. Plaque
index was expressed as the percentage of examined sites
with plaque accumulation.
After air-drying and plaque removal, all exposed cor-
onal and root surfaces were evaluated using a WHO
probe according to the modified International Caries
Detection and Assessment System (ICDAS) [13]. Molars
and premolars were considered to have five coronal sur-
faces and canines and incisors were considered to have
four. Codes were given as follows: sound (code 0), visual
change on enamel (code 1), distinct visual change on en-
amel (code 2), caries extended to dentin (code 3), filled
without decay (code 4), filled with decay (code 5),
arrested caries (code 6), missing (code 7), crowned
(code 8). Decayed, missing, or filled surface (DMFS)
score at baseline was computed by summing the
number of caries, missing and filled surfaces related
to caries. The exposed root surfaces were coded as
sound (code 0), no cavitation with discolored area
(code 1), cavitation with discolored area (code 2), or
arrested caries (code 6). Dental examination was car-
ried out at 12-month and 24-month.
Microbiological assessment
Lactobacilli were explored in the SWS and dental plaque
samples. The SWS and dental plaque samples were vor-
texed for 30s at maximum setting (Autovortex Mixer
SA2, Stuart Scientific, London, UK) and then serially di-
luted (10−2 and 10−3) with 0.01 M sterile PBS (pH = 7.2).
A 50-μl aliquot of the 1:100 and the 1:1000 dilutions
were duplicately spiral-plated (Spiral Systems Autoplate
4000 Spiral plater, Spiral Biotech, Norwood, Mass) on
Rogosa agar (Difco, Detroit, MI, USA). The Rogosa agar
plates were incubated for 3 days in an anaerobic cham-
ber (37 °C, 5% CO2 and 95% N2). Following incubation,
a stereomicroscope (Olympus TL, Tokyo, Japan) was
used to verify the presence of colonies. The colonies
were subcultured using blood agar plates (Oxoid,
Basingstoke, Hampshire, UK), which contained 5%
defibrinated blood, 0.0005% (5 mg/L) haemin and mena-
dione, to obtain pure isolates for identification. Identifi-
cation for lactobacilli was confirmed by colony
morphology, gram-stain reaction, Candida was explored
in the oral rinse and dental plaque samples.
Candida were explored in the oral rinse and dental
plaque samples. The samples were vortexed for 30s at
maximum setting and 1:10 diluted with 0.01 M sterile
PBS (pH = 7.2). To estimate the level of Candida in each
sample, a 50-μl aliquot of the undiluted (oral rinse
samples) and dilution samples (oral rinse and dental
plaque samples) were duplicately spiral-plated by using
the spiral plater onto the Sabouraud dextrose agar (SDA;
Oxoid, Unipath Ltd, Basingstoke, Hampshire, UK) and
CHROMagar (Becton Dickinson Europe, Le Pont de
Claix, France). All plates were incubated for 2 days at
37 °C in air. After incubation, plates with appropriate
number of colonies which were well separated and
evenly dispersed were chosen for counting. The number
of the colony in oral rinse and dental plaque samples
were recorded and expressed as CFU/ml. The selected
Candida colonies were subcultured on SDA plates to
obtain pure isolates. Candida was speciated and identi-
fied based on the followings: colony morphology in
CHROMagar and SDA, cell morphology, gram-stain reac-
tion, and result of the API ID 32C system (bioMérieux,
France) and RapID-ANA II system (Remel, Lenexa,
KS, USA).
Counts of lactobacilli and Candida were expressed as
colony forming units per milliliter (CFU/ml) in salivary
samples and colony forming units per gram in dental
plaque samples.
Study interventions
In the test group, topical fluoride varnish (5% NaF var-
nish, Duraphat®, Colgate, Colgate-Palmolive Company,
New York, USA) was applied; while in the control
group, a water-based gel without fluoride was used as
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placebo (K-Y® Gel, McNEIL-PPC Inc., Fort Washington,
USA). A trained clinician applied the fluoride varnish/
placebo gel that was dispensed by a dental surgery assist-
ant in single-dose vials with the name and record num-
ber of the subjects pre-labelled [14]. All teeth were dried
and isolated, and fluoride varnish/placebo gel was ap-
plied using a micro-brush to all teeth surfaces. Partici-
pants were asked to avoid drinking and eating during
the first two hours after application and to avoid eating
abrasive food on that day. The dental surgery assistant
escorted the patients to leave the clinics after application
of the agent, so as to avoid the contact between patients
and the examiner or the other patients in this study.
Follow-up visits were arranged every 3 months after
baseline for applications of fluoride varnish/placebo gel up
to 24 months. Dental condition and oral hygiene condi-
tion were recorded at the 12-month and 24-month visits,
as well as oral rinse, salivary and dental plaque samples
collection, and measurement of the relevant index (pH,
buffering capacity and microbiological profiles).
Statistical analysis
Differences in continuous variables between the fluoride
and placebo groups were tested by t-test or Mann-
Whitney U test for data which were normally or not
normally distributed respectively. Differences in categor-
ical variables between groups were tested by Chi-
squared tests or Fisher’s exact tests whichever was
appropriate. Repeated measures analysis of variance or
Friedman test, whichever was appropriate, was per-
formed for evaluating differences among the same
continuous variables of three-time point assessments
(baseline, 12-month and 24-month). Pearson’s correl-
ation or Spearman’s rank correlation, whichever was ap-
propriate, was used to explore associations between
parameters of interest.
Multivariate analysis of estimation of parameters in
occurrence of new caries increments is appropriate for
this dataset. The logistic model was applied to predict
the occurrence of caries over the 24-month period and
to explore the effectiveness of intervention. Potential risk
factors associated with development of new caries le-
sions was assessed by odds ratio through logistic regres-
sion analyses. Variables with a p-value of 0.10 or below
were entered into regression model (Forward selection)
for determination of significant factors. The level of sig-
nificance was set at 5% (p < 0.05). Data analysis was
processed using SPSS software (version 20.0).
Results
Recruitment and socio-demographic characteristics of
participants
The flow of the study is presented in Fig. 1. Among 114
recruited SS patients, 85 patients met the inclusion
criteria and received prebaseline treatment. They were
randomly allocated into the fluoride group (N = 43) and
the placebo group (N = 42). During the follow-up period,
seven patients (3 in the fluoride group and 4 in the pla-
cebo group) withdrew. No significant difference was
found between the seven drop-outs and the remaining
78 patients (35 pSS and 43 sSS), who were included for
data analysis. Out of the 78 patients, 76 (97%) were
women and the mean age was 50 years (SD = 9.9).
The average duration of diagnosis was 101.3 months
(SD = 78.6) (Table 1). More than 85% of the subjects
brushed their teeth twice or more per day and used
fluoride toothpaste. Approximately 75% of them prac-
tised interdental cleaning using dental floss or inter-
dental brush, while only one-third of them used
fluoride mouthrinse. There was no significant differ-
ence between subjects in fluoride and placebo groups
in terms of their regular oral hygiene habits and use
of fluoride products (p > 0.05), except the frequency
of tooth brushing and the use of fluoride toothpaste
(p < 0.05).There was no statistical significant difference
in the type of SS, gender, age, duration since diagno-
sis, education level or work status between the two
groups (p > 0.05).
Salivary flow rates, saliva pH, saliva buffering capacity
and dental conditions
Mean plaque index scores, DMFS, salivary flow rate and
pH of both groups at baseline were shown in Table 1.
There was no significant difference in these parameters
between the two groups (p > 0.05).
The mean salivary pH values over 24 months in fluor-
ide group and placebo group were within the normal
range. No statistically significant difference existed be-
tween the salivary flow rates, pH value and buffer cap-
acity of the fluoride group and placebo group (p > 0.05).
Most subjects developed caries with time in both
groups (Table 2). At 12-month, enamel caries accounted
for 63.6% of the caries lesions while at 24-month, en-
amel and dentin caries lesions were equally detected.
There was no significant difference in the distribution in
enamel lesions, dentin caries lesions and arrested caries
lesions between the two groups at 12-month and 24-
month visits (p > 0.05). The mean number of caries le-
sions developed in the maxillary and mandibular jaws
showed no statistically significant difference (p > 0.05).
More anterior teeth in the placebo group developed
dentin caries lesions than those in the fluoride group
(p < 0.05), but such difference was not observed in
premolars and molars (p > 0.05). More distal surfaces
in the placebo group developed dentin caries lesions
than those in the fluoride group (p < 0.05), however
the difference was not observed in the other surfaces.
The difference in the root caries increments between
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two groups was not statistically significant (p > 0.05).
Comparing the difference of the numbers of dentin
caries lesions at 24-month, the caries preventive frac-
tion of fluoride varnish in SS patients is 33.3%. Intra-
examiner reliability was 0.96 and 0.90 for coronal car-
ies and plaque index respectively.
DMFS at baseline correlated positively to the number
of new dentin caries developed at 24-month in the
fluoride (rs = 0.43, p = 0.005) and the placebo (rs = 0.37,
p = 0.02) groups. In addition, F-component of DMFS at
baseline showed a positive correlation to the number of
new dentin caries at 24-month in the fluoride (rs = 0.40,
p = 0.01) and the placebo (rs = 0.36, p = 0.03) groups.
As less than the original estimated sample size was
recruited, post-hoc power calculation was conducted.
According to the initial sample size determination, 38
Fig. 1 CONSORT flow diagram of this randomized trial
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subjects per group would provide 80% power to detect a
preventive fraction of 42.8%, i.e., estimated 24-month
mean caries increment of fluoride group would be 2 sur-
faces (SD = 1.6).
Intra-examiner reliability was 0.96 for coronal caries
and 0.90 for plaque index.
Microbiology
The mean counts of lactobacilli and Candida at the vari-
ous time-points and sites were shown in Table 3. There
was no statistically significant difference in the preva-
lence of species and the mean counts of lactobacilli and
Candida between the two groups at baseline and 24-
month (p > 0.05). Correlations (rs) between the mean
counts of the microbes in the saliva and dental plaque
and the mean salivary flow rates and new various lesions
were presented in Table 3.
The most predominantly isolated lactobacilli were
L. fermentum. Others lactobacilli species isolated in-
cluded L. acidophilus, L. minutis and L. casei.
Table 1 Socio-demographic features, oral hygiene practice and baseline condition by group
Fluoride group (N = 40) Placebo group (N = 38) p-value
Type of SS (primary: secondary) (%) 45.0 : 55.0 44.7 : 55.3 N.S.
Gender (Female: Male) (%) 97.3 : 2.7 97.4 : 2.6 N.S.
Age at baseline (years)
Mean (SD) 49.2 (9.1) 50.9 (10.8) N.S.
Range 29–71 26–75
Time since diagnosis (months)
Mean (SD) 117.5 (97.1) 84.2 (48.4) N.S.
Range 3–425 2–177
Education level (%)
Primary school or below 30.0 21.1 N.S.
Secondary school or above 70.0 78.9
Employed (%) 62.5 44.7
Oral hygiene practice (%)
Brushed twice or more per day 100.0 89.5 0.001
Practised interdental cleaning 70.0 78.9 N.S.
Daily use of fluoride (%)
Toothpaste 87.5 100.0 <0.001
Mouthrinse 37.5 34.2 N.S.
Three meals or less per day (%) 90.0 89.5 N.S.
Saliva
Unstimulated whole saliva
Mean flow rate (SD), range 0.22 (0.24), 0–0.99 0.26 (0.26), 0–1.12 N.S.
Mean pH (SD), range 7.2 (0.4), 6.3–8.3 7.3 (0.5), 6.3–8.5 N.S.
Stimulated whole saliva N.S.
Mean flow rate (SD), range 0.48 (0.58), 0–2.60 0.51 (0.47), 0–1.73 N.S.
Mean pH (SD), range 7.8 (0.4), 6.8–8.6 7.7 (0.5), 6.5–8.5 N.S.
Dental condition
Mean number of teeth (SD), range 26.6 (3.0), 18–32 26.7 (3.8), 12–32 N.S.
Mean DMFS (SD), range 45.6 (18.8), 4–78 41.2 (23.1), 1–114 N.S.
Mean DS (SD), range 0.9 (1.1), 0–4 0.9 (0.9), 0–4 N.S.
Mean MS (SD), range 25.0 (13.7), 0–65 25.7 (18.6), 0–94 N.S.
Mean FS (SD), range 19.8 (12.5), 0–54 14.7 (10.6), 0–43 0.06
Mean plaque index (SD) (%) 28 (25), 0–88 33 (26), 4–100 N.S.
Removable partial denture wearers (%) 7.5 13.2 N.S.
N.S. not significant
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C. albicans was the most frequently isolated
Candida species, other Candida species such as C.
dubliniensis, C. tropicalis, C. glabrata, C. sake and C.
parapsilosis. More than 10% of patients in both
groups had mixed Candida colonization in saliva and
dental plaque samples, usually C. albicans with another
Candida species.
The odds ratio of SS patients receiving fluoride var-
nish who developed dentin caries was 0.22 (Table 4).
The odds ratios per unit increase in the mean num-
ber of Candida species in dental plaque and mean
UWS pH of dentin caries development were 5.189
(95% CI: 1.307, 20.602) and 0.052 (95% CI: 0.006,
0.414) respectively. Logistic regression analysis re-
vealed that SS patients who received placebo (p <
0.05), presented with low UWS pH (p < 0.01) and had
high baseline DMFS level (p = 0.050) were significantly
more likely to develop dentin caries when compared
to their counterparts.
SS patients who had high UWS buffering capacity
(p < 0.05) and harbored high level of Candida in the
oral rinse samples (p < 0.05) were significantly more
likely to have caries arrested at 24-month as com-
pared to their counterparts (Table 5). Those with high
UWS buffer capacity were five times as likely as those
with low or medium UWS buffer capacity to have
arrested caries lesions.
Discussion
SS patients who received quarterly applied fluoride var-
nish developed 32.5% less coronal dentin caries than
those who received a placebo, which was similar to the
result obtained in a study on hyposalivated patients who
self-administered 0.05% NaF mouthrinse 3 times daily
[15]. The caries preventive fraction of fluoride varnish in
SS patients is similar to that of other groups of subjects
[16]. Although subjects in the placebo group developed
higher mean new caries lesions than the fluoride group,
the differences were not statistically significant. Type II
error may be responsible for the apparent lack of differ-
ence in caries increments between the two groups as less
SS subjects were recruited than estimated. On the con-
trary, when other confounding factors were controlled,
the odds ratio of dentin caries development was signifi-
cantly lower in the fluoride varnish group than the pla-
cebo group. Such contradicting findings imply a lack of
clear evidence to support or refute the hypothesis that
quarterly applied fluoride varnish can prevent caries de-
velopment in this group of patients. Nevertheless, it is
interesting to note that SS subjects in this study were
generally having high dental awareness and their level of
oral hygiene was satisfactory. Caries experience as
reflected in the number of standing teeth and DMFS is
even comparable to some non-SS subjects in other stud-
ies [17, 18]. In addition, more than 30 and 50% of them
Table 2 Different types of lesions at the subject and surface levels
12-month 24-month
Group Fluoride group (N = 40) Placebo group (N = 38) p-value Fluoride group (N = 40) Placebo group (N = 38) p-value
Number of subjects (%)
No caries 15 (37.5) 19 (50) N.S. 11 (27.5) 12 (31.8) N.S.
Enamel lesion 19 (47.5) 15 (39.4) N.S. 21 (52.5) 18 (47.4) N.S.
Dentin lesion 4 (10) 8 (21.1) 13 (32.5) 16 (42.1)
Arrested lesion 7 (17.5) 5 (13.2) 10 (25.0) 14 (37.5)
Number of surface
Enamel lesion
Sum 41 34 N.S. 64 60 N.S.
Mean (SD) 1.0 (1.5) 0.9 (1.5) 1.6 (2.3) 1.6 (2.5)
Range 0–6 0–7 0–10 0–11
Dentin lesion
Sum 8 35 N.S. 55 78 N.S.
Mean (SD) 0.2 (0.6) 0.9 (2.4) 1.4 (2.6) 2.1 (4.2)
Range 0–3 0–11 0–11 0–22
Arrested lesion
Sum 17 13 N.S. 22 25 N.S.
Mean (SD) 0.4 (1.2) 0.3 (1.2) 0.6 (1.3) 0.7 (1.3)
Range 0–6 0–6 0–7 0–7
N.S. not significant
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presented with normal range of UWS and SWS flow
rates respectively. Salivary flow rate, UWS in particular,
has been shown to negatively associate with caries devel-
opment [19].
In this study cohort, both the number of root caries
and root caries increment were low. An earlier cross-
sectional study of SS patients has revealed a mean
decayed or filled root surface of 5.3 which was 10 times
as that in the current study cohort [20]. Caries incre-
ments in both groups were much lower than the esti-
mated mean annual root caries increment in the general
older population [21]. Hence, efficacy of fluoride varnish
Table 3 Correlations (rs) between the mean numbers of species carried, mean counts of Candida in the oral rinse samples and
dental plaque samples and the mean salivary flow rates and new caries lesions
Fluoride group (N = 40) Placebo group (N = 38)
Saliva samples
Lactobacilli Candida Lactobacilli Candida
Mean counts (×104 CFU/ml) (SD) Baseline 1.6 (4.6) 591.5 (1705.1) 8 (25.8) 184.3 (369.3)
Over 24-months 6.3 (14.2) 428.3 (828.2) 13.7 (45.6) 291.6 (541.1)
Mean counts
Correlations (rs) Lactobacilli Candida Lactobacilli Candida
Mean salivary flow rates Unstimulated whole saliva −0.37* −0.67** 0.44** −0.77**
Stimulated whole saliva −0.38* −0.69** −0.39* −0.77**
New lesions (over 24 months) Enamel lesion −0.03 −0.19 0.17 −0.02
Dentin lesion 0.40** 0.53** 0.35* 0.56**
Arrested lesion 0.25 0.44** 0.24 0.32
Dental plaque samples
Lactobacilli Candida Lactobacilli Candida
Mean counts (×106 CFU/g) (SD) Baseline 15.8 (62.5) 60.2 (172.9) 1.7 (6.3) 9.5 (20.4)
Over 24-months 56.6 (178.9) 37.2 (73.5) 119.1 (444.6) 40.9 (164.0)
Mean counts
Correlations (rs) Lactobacilli Candida Lactobacilli Candida
Mean salivary flow rates Unstimulated whole saliva 0.51** −0.53** −0.69** −0.75**
Stimulated whole saliva −0.48** −0.58** −0.69** −0.79**
New lesions (over 24 months) Enamel lesion 0.11 −0.05 0.04 −0.04
Dentin lesion 0.44** 0.45** 0.47** 0.48**
Arrested lesion 0.26 0.38* 0.33* 0.32
* Significant Spearman’s correlation p < 0.05
** Significant Spearman’s correlation p < 0.01
Table 4 Final logistic regression model for the occurrence of
new dentin caries lesions in SS patients over a 24-month period
Adjusted
Odds
ratio
95% confidence
interval
Factors P-value Lower Upper
Intervention (Ref. = placebo group) 0.035 0.221 0.054 0.901
Mean number of Candida species
in the dental plaque samples
0.019 5.189 1.307 20.602
Mean pH of unstimulated whole
saliva over 24 months
0.005 0.052 0.006 0.414
DMFS (at baseline) 0.05 1.033 1.000 1.067
Table 5 Final logistic regression model for the occurrence of
new arrested caries lesions in SS patients over a 24-month period
Adjusted
Odds
ratio
95% confidence
interval
Factors P-value Lower Upper
Intervention (Ref. = placebo group) 0.054 0.315 0.097 1.022
Buffering capacity of unstimulated
whole saliva at baseline
(Ref. = medium and low)
0.017 5.018 1.339 18.804
Mean counts of Candida in oral rinse
samples over 24 months
0.015 1.002 1.000 1.003
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in root caries prevention in SS patients cannot be
discerned.
Reduced salivary flow rate leads to changes in
some specific components of saliva, including the
immunoglobulins (secretory IgA, IgG, and IgM), antibac-
terial protein (lysozyme, lactoferrin, peroxidases) and the
concentrations of electrolytes (sodium, chloride, and
phosphate) [17]. In addition, reduced salivary output may
hinder mechanical flushing of microorganisms from teeth
surfaces [22]. Therefore, antibacterial activity of saliva is
decreased and bacteria can flourish in the mouth of SS pa-
tients. Despite the fact that salivary pH of most SS sub-
jects in this study was within normal range, a negative
correlation between salivary pH and development of new
dentin lesions was detected and low UWS pH was found
to be a strong predictor of dentin lesions development.
Rates of the demineralization and remineralization of den-
tal hard tissues are pH-mediated [23]. At neutral pH (7.0),
saliva is supersaturated with calcium phosphate. However,
when the pH decreases to a point where the saliva ceases
to be supersaturated, the hydroxyapatite crystals begin to
dissolve and demineralization occurs. It has been reported
that UWS pH in SS patients can be as low as only one
tenth of a pH unit above the mean critical pH [17]. A mi-
nute drop in pH, hence, can lead to undersaturation of hy-
droxyapatite that results in either caries lesions or erosive
damage to the teeth depending on the origin of the acidic
challenge. In addition, acidic oral environment is highly
suitable for the survival and proliferation of cariogenic
bacteria. Acidic saliva has poor ability to maintain oral
homeostasis. When the saliva pH level decreases, the risk
of dentin caries development increases.
Buffering capacity of saliva is in fact more critical than
its pH value in oral homeostasis [24]. Results of the lo-
gistic regression revealed that occurrence of new
arrested caries lesions was related to the level of the
buffering capacity of UWS. Arrested lesions are the re-
sult of remineralization of a demineralized lesion and
the buffering capacity of saliva plays a critical role in
helping to restore a neutral pH at the tooth surface and
to increase the rate of remineralization [25]. Although
some studies showed that the salivary bicarbonate and
phosphate concentrations of SS patients were lower than
those of healthy subjects [17], in this study, more than
80% of SS patients had medium to high salivary buffer-
ing capacity, hence enamel and dentin caries lesions in
these patients can be remineralized and became arrested
lesions.
The oral environment of SS patients does not favor
the growth of S. mutans because the saliva pH was
higher than the optimal pH that supports its growth.
Furthermore, S. mutans and Candida species do not
coaggregate well [26]. The high oral prevalence of
Candida (55–65%) may prevent the colonization of S.
mutans in this study population. The result suggests that
fluoride varnish has little effect on the level of lactoba-
cilli in SS patients, which is in agreement with that re-
ported in other studies [27]. Some study found that NaF
at one mmol/L could only inhibit the growth of less than
half of oral lactobacilli species [28]. The low concentra-
tion of fluoride (1.2 mmol/L NaF) in fluoride varnish
cannot inhibit the growth of oral lactobacilli. Further-
more, the concentration of fluoride cannot be main-
tained as it would gradually decline with time after
application. An in-vitro study has demonstrated that
fluoride varnish could release fluoride for five to
6 months and the mean concentration was about
0.025 mmol/L [29].
In this study, Candida counts were found to be posi-
tively correlated to the number of new dentin caries le-
sions. Candida produces proteolytic enzymes which can
break down the organic collagen matrix of dentin [30].
Furthermore, the penetrating power of hyphae from en-
amel into dentin seems to support that Candida has a
crucial role in dental caries development [31]. Mixed
colonization of Candida spp. was observed in about 10%
of the SS subjects which generally occurs in patients
with impaired immunological function [32, 33]. From re-
sults of the logistic regression, the more types of Can-
dida spp. detected in dental plaque, the higher likelihood
of dentin caries development. Host dental plaque biofilm
provided a favorable acidic condition for Candida
growth and proliferation, because most yeasts optimally
grow at pH 5.5–6 [34]. Hence, patients harboring more
Candida species would have a higher risk of
demineralization and dissolution of hydroxyapatite.
Nonetheless, the results should be interpreted with
caution as one major limitation of this study is the small
population size. Only 85 patients were recruited which
fell short of the original estimated sample size. Insuffi-
cient sample size would lower the statistical power and
lead to type II error that might account for the apparent
lack of difference in caries increments between the treat-
ment and placebo groups. Furthermore, the length of
this study might not be sufficient to fully explore the ef-
ficacy of fluoride varnish in caries prevention as caries
development is a slow process, despite the fact that SS
patients are at high caries risk.
Conclusions
Results of this randomized clinical trial did not provide
clear evidence to support or refute that quarterly appli-
cations of fluoride varnish can prevent development of
dental caries in people with Sjögren’s syndrome.
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